Abstract

Anti-CD47 and Anti-PDL1 Immunotherapy Synergize for Anti-tumor Activity in Preclinical Models of Head and Neck Cancer

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call